Patient Guide: An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 28 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04076059
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Hormone Sensitive Prostate Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 28 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing,
  • Beijing,
  • Changchun,
  • • And 25 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily